ArticleAmerican journal of respiratory and critical care medicine2014
The lung microbiome in idiopathic pulmonary fibrosis. What does it mean and what should we do about it?
Article in American journal of respiratory and critical care medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- MDPD reveals specific microbial signatures in human pulmonary diseases.Briefings in bioinformatics · 2026Article
- Assessing the impact of triiodothyronine treatment on the lung microbiome of mice with pulmonary fibrosis.BMC pulmonary medicine · 2024Article
- Lung Microbiota in Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis, and Unclassified Interstitial Lung Diseases: A Preliminary Pilot Study.Diagnostics (Basel, Switzerland) · 2023Article
- Immune-mediated lung diseases: A narrative review.Frontiers in medicine · 2023Review
- The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis.International journal of molecular sciences · 2019Review
- Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.American journal of respiratory and critical care medicine · 2019Article
- Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients.Frontiers in cellular and infection microbiology · 2019Article
- Idiopathic Pulmonary Fibrosis: Epidemiology, Natural History, Phenotypes.Medical sciences (Basel, Switzerland) · 2018Review
- Article
- The respiratory microbiome in idiopathic pulmonary fibrosis.Annals of translational medicine · 2017Review
- 'The Microbiome and the Pathophysiology of Asthma'.Respiratory research · 2016Review
- The value of macrolides in the adjuvant treatment of pulmonary fibrosis: maybe a panacea.Therapeutic advances in respiratory diseaseReview
Corrections and comments
- Comment on
Authors and funding
3 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
25317462What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.